“McKesson supports cancer research through a community‑based clinical trial infrastructure. We partner with biopharma to advance the science of cancer treatments through our joint venture, Sarah Cannon Research Institute (SCRI).”
“McKesson plays a critical role in preserving and strengthening community care by connecting scale, capabilities and expertise to help providers deliver high‑quality, accessible care while supporting affordability for patients and payers. Through The US Oncology Network, we streamline logistical and administrative access to complex medications and support timely, high‑quality care for patients.”
“Through Ontada and partnerships with The US Oncology Network, we provide responsibly governed real-world data, research and provider education to accelerate drug development, inform market strategies, and improve health outcomes.”
“With Biologics by McKesson specialty pharmacy services, we simplify access to therapies and delivers personalized, high-touch support for cancer, cell and gene, and rare disease patients. Through InspiroGene, we deliver complex cell and gene therapies directly to patients and providers, advancing innovative treatment delivery.”
“From workforce burnout to fragmented data, providers face unprecedented challenges, and emerging technologies with AI capabilities show promise in helping to simplify complexity.”
Download this profile and inspect its supporting evidence.